Page last updated: 2024-10-21

phenytoin and Intracranial Arteriosclerosis

phenytoin has been researched along with Intracranial Arteriosclerosis in 1 studies

Intracranial Arteriosclerosis: Vascular diseases characterized by thickening and hardening of the walls of ARTERIES inside the SKULL. There are three subtypes: (1) atherosclerosis with fatty deposits in the ARTERIAL INTIMA; (2) Monckeberg's sclerosis with calcium deposits in the media and (3) arteriolosclerosis involving the small caliber arteries. Clinical signs include HEADACHE; CONFUSION; transient blindness (AMAUROSIS FUGAX); speech impairment; and HEMIPARESIS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
JANZ, D1
KAUTZ, G1

Other Studies

1 other study available for phenytoin and Intracranial Arteriosclerosis

ArticleYear
[ETIOLOGY AND THERAPY OF STATUS EPILEPTICUS].
    Deutsche medizinische Wochenschrift (1946), 1963, Nov-08, Volume: 88

    Topics: Abortion, Septic; Anticonvulsants; Birth Injuries; Brain Injuries; Brain Neoplasms; Chloral Hydrate;

1963